This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
3 Citations 5 Q&As
3 Citations 12 Q&As
1 Citations 16 Q&As
1 Citations 6 Q&As
Facts about Fibroblast growth factor 21.
.
Human | |
---|---|
Gene Name: | FGF21 |
Uniprot: | Q9NSA1 |
Entrez: | 26291 |
Belongs to: |
---|
heparin-binding growth factors family |
FGF21; FGF-21; fibroblast growth factor 21
Mass (kDA):
22.3 kDA
Human | |
---|---|
Location: | 19q13.33 |
Sequence: | 19; NC_000019.10 (48755524..48758330) |
Secreted.
In this article we review the current research on activation and nuclear translocation of TFEB and FGF21. We also review the limitations of this study and discuss possible future applications. The results are applicable to researchers from any country. Furthermore, they provide the most popular and significant uses of this protein within the biological system. Here are the major benefits and drawbacks of this present study.
TFEB and TFE3 (its coactivator) are the master regulators for adaptive changes in lysosomal capacity and selective autophagy. This axis is necessary to activate TFEB during mitophagy or xenophagy. GABARAP plays a role in autophagy via membrane conjugation by sequestering FLCN FNIP. However, how TFEB is activated during autophagy is still not understood.
The activation of TFEB reduces cell death by promoting autophagy, which reduces ROS levels in cells. TFEB also serves an antioxidant role against oxidative stress, by preventing the process of apoptosis as well as H2O2-induced oxid injury. These results are consistent with previous reports on non-ruminants. The results of this study are also consistent with previous research in animal models.
TFEB activates DNA repair pathways. These molecules can be activated by a variety of DNA-damaging stimuli. Although the mechanisms of their actions differ, they both respond to genotoxic stress the same way. Both TFEB and TFE3 are also crucial for controlling the immune response to certain types of DNA damage. Therefore, we should focus our efforts on understanding how they activate or function.
Activating TFEB increases autophagy by encouraging the release of lysosomal proteins and increasing autophagic flux. Additionally, TFEB activates the pathway by upregulating the abundance of LC3-II as well as p62 proteins. It is also involved in the elimination of the storage material triggered by lysosomal disorders. By activating TFEB increases autophagic flux and facilitates phagosome production, which reduces oxidative stress.
Mutations of TFEB, TFE3, and TFE3 hinder the cellular response to DNA damage. Their lower levels could result in a more rapid cell cycle arrest and the inability to trigger anapoptosis. Additionally, they could be associated with persistent genotoxic stress that contributes to the progression of cancer. Therefore, we suggest that this research be replicated in an individual human population to better know how these two proteins interact.
FGF21 is expressed in human cells in a variety cell types that include leukemia patients. Several different methods have been employed to analyze the FGF21 gene and its effects on nuclear translocation. The most popular methods involve transfection of the gene using synthetic DNA fragments (AAV) and then determining its expression by quantitative PCR. These methods are not the best to determine the role of FGF21 in nuclear translocation.
Autophagy is a conserved function in eukaryotic cell. Research suggests that FGF21 promotes the autophagy process and enhances the survival of the cells of the eukaryotic family. However, it is to be noted that autophagy is not beneficial for every setting of ischemia. It is especially important for the random flap model. Furthermore, the protective effects of FGF21 on autophagy remain to be established.
The activation of TFEB is necessary for cell growth and proliferation. It is also responsible for regulating the final phases of embryonic development mice. Activation of TFEB triggers the expression of genes involved in the G1-S cell cycle transition. Depletion of TFEB in oral squamous cell carcinoma results in diminished invasive and migratory capabilities. This effect is thought to be due to lower levels of miT/TFE protein.
FGM-21 activates TFEB which stimulates embryogenesis-related vacuoles. The mutants of this gene exhibit an extreme scoliosis phenotype however, TFEB knockout mouse exhibit embryonic lethality as well as altered placental vascularization. FGF21 stimulates TFEB and plays a variety of crucial roles in vertebrate growth.
Activation of TFEB by FGM21 leads to increased levels of autophagy, which is a kind of detoxifying and repair enzyme that is a cell. Autophagy is a key to prolonging the lifespan. This process aids in the synthesis of fatty acids. It also helps the cell cope with nutrient-deficiency. Additionally activation of TFEB enhances levels of autophagy , as well as lysosomal biogenesis.
Activation of TFEB by Fgf21 in boster bio has important implications for the development of healthy liver. The activation of FGF21 of TFEB in boster-bio mice is linked to increased cell proliferation as well as the transition to an embryonic cholangiocyte-like phenotype. TFEB also regulates SRY-9 transcription factor 9 (SOX9). This regulates biliary gene expression and blocks the hepatocytes' gene expression. The overexpression of SOX9 stimulates cholangiocarcinoma as well as inhibits the hepatocytes.
The activation of TFEB helps animals avoid obesity caused by diet. It stimulates genes involved in lipolysis and antioxidant metabolism and stimulates the production of glycogen. Additionally, TFE3 inhibits fatty acid supply to BAT and decreases thermogenesis. TFE3 overexpression causes mTORC1-mediated inhibition in autophagy that is mediated by TFE3.
Although there isn't any definitive evidence linking poor sleep with electronic media use there is a possibility. However, the cross-sectional design of this study does not rule out the possibility that both are connected. If there is one, is likely to reflect a self perpetuating cycle, particularly as teens may use electronic media as a sleep aid. These limitations shouldn't be overlooked. This study is crucial for identifying the gaps in the literature and describing the need for further research.
It is important to state clearly the limitations when claiming these limitations. The most serious flaws that are found in the methodology of a study will diminish its credibility and leave the reader wondering whether the study will actually affect the problem. Instead, the limitations should be critically evaluated and interpreted. It is important to include these aspects in your evaluation:
The study's design and method are also crucial factors for the interpretation of the findings. Without these aspects the findings might not be valid and generalizable. These aspects can be used to aid researchers in understanding the implications of the study's design as well as its limitations. This article will explore the implications of limitations on the study's conclusions. Let's look at the various types of limitations. What are they and what are their implications?
Research papers should clearly define the limitations of the study. These limitations should not be used as a reason for poor work. For instance, a lack of rigor might indicate that the topic to be studied isn't recent enough or too specific to warrant further research. The limitations must be clearly and concisely explained. In addition to highlighting the weaknesses of the study, it is important to point out the ways in which the limitations of the study impacted the results. You may need to do more research to resolve some of the issues.
Exogenous FGF21 increased the expression of the KLB gene in males, but not females. These results suggest that exogenous FGF21 might not be suitable for clinical use. Future research should look into the factors that affect FGF21 expression and the significance of exogenous FGF21 in the behavior of KLB.
The mRNA that encodes human FGF21 was codon optimized to the production of luciferase. The mRNA was synthesized in vitro using 1-methylpseudo-uridine UTP. The DNA template that resulted was linearized and included the 5', 3', and open reading frames and the poly A tail. The vaccinia enzyme is used to cap the mRNA following transfection.
PMID: 10858549 by Nishimura T., et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver.
PMID: 15902306 by Kharitonenkov A., et al. FGF-21 as a novel metabolic regulator.
*More publications can be found for each product on its corresponding product page